| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.5 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |